Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sinocelltech Group Ltd

688520
Current price
34.93 CNY +1.02 CNY (+3.01%)
Last closed 33.76 CNY
ISIN CNE100003ZL3
Sector Healthcare
Industry Biotechnology
Exchange Shanghai Stock Exchange
Capitalization 15 033 312 812 CNY
Yield for 12 month -30.28 %
1Y
3Y
5Y
10Y
15Y
688520
21.11.2021 - 28.11.2021

Sinocelltech Group Limited, a biotech company, engages in the research and development, and industrialization of recombinant proteins, monoclonal antibodies, and vaccines in China. The company offers AnpingxiA (repertuzumab injection), an anti-tumor product; Anjiayin for the treatment of the rare disease hemophilia A; coronavirus 2-valent, a trimer protein vaccine; and mutant strain recombinant protein vaccines SCTV01C and SCTV01E. Its pipeline products include SCT630 used for the treatment of autoimmune diseases; SCT510 for the treatment of solid tumors; SCT-I10A, a monoclonal antibody injection which is in phase 3 trials for the treatment of solid tumors; SCTV01, a new generation vaccine which is in phase 3 trials for the treatment of corona virus; SCT510 for the treatment of solid tumors; SCT200, a monoclonal antibody injection for the treatment of solid tumors; and SCT1000, which is in phase 3 clinical trials for the treatment of human papillomavirus, as well as SCTA01 which is in phase 2/3 clinical research trials for the treatment of SARS COV-2. The company was founded in 2007 and is based in Beijing, China. Sinocelltech Group Limited operates as a subsidiary of Lhasa Alike Investment Consulting Co., Ltd. Address: No. 31 Kechuang 7th Street, Beijing, China, 100176

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

476.55 CNY

P/E ratio

Dividend Yield

Current Year

+1 887 194 860 CNY

Last Year

+1 023 092 954 CNY

Current Quarter

+692 109 631 CNY

Last Quarter

+612 453 234 CNY

Current Year

+1 832 657 845 CNY

Last Year

+989 219 209 CNY

Current Quarter

+668 041 374 CNY

Last Quarter

+591 968 758 CNY

Key Figures 688520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 613 405 800 CNY
Operating Margin TTM 32.95 %
PE Ratio
Return On Assets TTM 10.22 %
PEG Ratio
Return On Equity TTM -3 864.41 %
Wall Street Target Price 476.55 CNY
Revenue TTM 2 444 878 701 CNY
Book Value -0.96 CNY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 10.70 %
Dividend Yield
Gross Profit TTM 2 305 884 380 CNY
Earnings per share -0.060 CNY
Diluted Eps TTM -0.060 CNY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 223.60 %
Profit Margin -1.07 %

Dividend Analytics 688520

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History 688520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 688520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 7.10
Price Sales TTM 6.13
Enterprise Value EBITDA 203.99
Price Book MRQ

Financials 688520

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 688520

For 52 weeks

31.07 CNY 52.60 CNY
50 Day MA 38.17 CNY
Shares Short Prior Month
200 Day MA 39.59 CNY
Short Ratio
Shares Short
Short Percent